The biology of FoxP3: AKey player in immune suppression during infections, autoimmune diseases and cancer

Advances in Experimental Medicine and Biology

Volumn 665, Issue , 2009, Pages 47-59

  Mercer, Frances ^b   Unutmaz, Derya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 7; ISOPROTEIN; LEUCINE ZIPPER PROTEIN; PROLINE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; CANCER IMMUNOLOGY; CELL MATURATION; CELL THERAPY; ENTERITIS; EPIGENETICS; GENE MUTATION; GENETIC REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; LYMPHOCYTE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; ORGAN TRANSPLANTATION; PARASITOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; TRANSLATION REGULATION; VIRUS INFECTION; ANIMAL; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; NEOPLASM; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

MUS;

ANIMALS; AUTOIMMUNE DISEASES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSION; INFECTION; NEOPLASMS; T-LYMPHOCYTES;

EID: 77952472919     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1599-3_4     Document Type: Article

References (107)

1. Fontenot JD. Gavin MA. RudenskyAY. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol2003; 4(4) :330-336. (Pubitemid 36432314)
2. Hori S. Nomura T. Sakaguchi S. Control of regulatory T-cell development by the transcription factor Foxp3. Science 2003; 299(5609) :1057-1061. (Pubitemid 36222930)
3. Wildin RS, Ramsdell F,PeakeJ, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27(1) :18-20. (Pubitemid 32044512)
4. Bennert CL, ChristieJ. Ramsdell F, et al. The immune dysregularion, polyendocrinopathy, enteropathy. X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27(1) :20-21. (Pubitemid 32044513)
5. Oswald-Richter K, Grill SM, Shariat N, et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Bioi 2004; 2(7) :EI98.
6. Aarcs-RiemensT. Emmelor ME. Verdonck LF, et al. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T-cells from CD4(+)CD25(-) cells. EurJ Immunol 2008; 38(5) :1381-1390.
7. O'Garra A, Vieira P. Twenty-firsr cenmry Foxp3. Nat Immunol2003; 4(4) :304-306.
8. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T-cells suppress polyclonal T-cell activation in viero by inhibiting interleukin 2 producelon.J Exp Med 1998; 188(2):287-296. (Pubitemid 28357757)
9. Zwar TD, van Driel IR, Gleeson PA. Guarding the immune system: Suppression of autoimmunity by CD4+CD25+ immunoregulatory T-cells. Immunology and Cell Biology 2006; 84(6) :487-501. (Pubitemid 44657021)
10. Sakaguchi S, Wing K. Miyara M. Regulatory T-cells-a brief history and perspective. EurJ Immunol 2007; 37(Suppll):SI16-123.
11. Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression-a diverse arsenal for a moving target. Immunology 2008; 124(1):13-22. (Pubitemid 351537583)
12. Torgerson TR, Ochs HD. Immune dysregulanon, polyeadocrinopathy, enteropathy, X-linked syndrome: A model of immune dysregulation. Curr Opin Allergy Clin Immunol 2002; 2(6) :481-487. (Pubitemid 36105810)
13. Li B. Greene MI. FOXP3 actively represses eranscription by recruiting the HAT/HDAC complex. Cell Cycle 2007; 6(12) :1432-1436.
14. Li B, Sarnanra A. Song X, et al. FOXP3 ensembles in T-cell regulation. Immunol Rev 2006; 212:99-113. (Pubitemid 44116703)
15. Campbell DJ. Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T-cells. Nat Rev Immunol 2007; 7(4):305-310. (Pubitemid 46480960)
16. Gambineri E, Torgerson TR, Ochs HD. Immune dysregularion, polyendocrinopathy, enteropathy and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3. A critical regulator ofT-cell homeostasis. Curr Opin Rheumatol 2003; 15(4):430-435. (Pubitemid 36774255)
17. Zheng Y. Rudensky AY. Foxp3 in control of the regulatory T'-cell lineage. Nat Immunol 2007; 8(5):457-462. (Pubitemid 46605910)
18. Brunkow ME, Jeffery EW; Hjerrild K.A., et al. Disruption of a new forkhead/winged-helix protein. scurtin, results in the fatallymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27(1) :68-73. (Pubitemid 32044521)
19. Wu Y. Borde M. Heissmeyer V, et al. FOXP3 controls regulatory T-cell function through cooperation with NFAT. Cell 2006; 126(2):375-387. (Pubitemid 44092960)
20. Bertelli E. Damange M. Oukka M. Foxp3 interacts with nuclear factor of activated T-cells and NF-kappa B to repress cyeokine gene expression and effector functions of T helper cells. Proc Nad Acad Sci USA 2005; 102(14) :5138-5143
21. Tao R. de Zoeten EF. Ozkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T-cells. Nat Med 2007; 13(11):1299-1307 (Pubitemid 350073591)
22. Zheng Y. Josefowicz SZ. Kas A, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T-cells. Nature 2007; 445(7130):936-940.
23. Ono M, Yaguchi H. Ohkura N, et al. Foxp3 controls regulatory T-cell function by interacting with AMLl/Runx1. Nature 2007; 446(7136):685-689. (Pubitemid 46606883)
24. Li B, Samanta A, Song X, et al. FOXP3 interactions with histone acetyltransferase and class II histone deacerylases are required for repression. Proc Nad Acad Sci USA 2007; 104(11) :4571-4576. (Pubitemid 47186266)
25. Chen C, RowellEA, Thomas RM, et al. Transcriptional regulation by Foxp3 is associatedwith direct promoter occupancy and modulation of histone acetylation.J Bioi Chern 2006; 281(48) :36828-36834. (Pubitemid 46042151)
26. Fontenot JD, RasmussenJP. Williams LM, et al. Regulatory T-cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22(3) :329-341. (Pubitemid 40387475)
27. Ziegler SF. FOXP3: Of mice and men. Annu Rev Immunol 2006; 24:209-226.
28. Zhou L, Lopes JE Chong MM, et al. TGF-beta-induced Foxp3 inhibits T(H) 17 cell differentiation by antagonizing RORgammat function Nature 2008; 453(7192) :236-240. (Pubitemid 351667978)
29. Smith EL, Finney HM, Nesbitt AM, et al. Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology 2006; 119(2) :203-211. (Pubitemid 44401639)
30. Du J, Huang C, Zhou B, et al. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J Immunol 2008; 180(7):4785-4792.
31. Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurfin in CD4+CD25+ T-regulacory cells. Nat Immunol2003; 4(4) :337-342. (Pubitemid 36432315)
32. Sugimoto N, Oida T, Hirota K, et al. Foxp3-dependent and -independenc molecules specific for CD 25+CD4+ natu ral regulatory T-cells revealed by DNA microarray analysis. Inr Immunol 2006; 18(8):1l97-1209.
33. Gavin MA, Rasmussen JP, Fontenot JD, et al. Foxp3-dependent programme of regulatory T-cell differentiation Nature 2007; 445(7129) :771-775. (Pubitemid 46279714)
34. Lin W, Haribhai D, Reiland LM, et al. Regulatory T-cell development in the absence of functional Foxp3. Nat Immunol 2007; 8(4):359-368. (Pubitemid 46745411)
35. Chen W, Jin W, Hardegen N, et al. Conversion of per ipheral CD4+CD25- naive T-cells to CD4+CD25+ regulatory T-cellsby TGF-beta induction of transcription factor Foxp3. J Exp Med 2003: 198(12):1875-1886. (Pubitemid 38032120)
36. Fantini MC, Becker C, Monteleone G, et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T-cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172(9) :5149-5153. (Pubitemid 38542009)
37. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T-cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype Blood 2007; 1l0(8):2983-2990. (Pubitemid 350006952)
38. Shevach EM, Tran DQ, Davidson TS, et al. The critical contribution of TGF-beta co the induction of Foxp3 expression and regulacoryT-cell function. Eur J Immunol2008: 38(4) :915-917.
39. Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effecror cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19(4):345-354. (Pubitemid 46523383)
40. Wang J, Ioan-Facsinay A, van der Voort EI, et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T-cells. Eur J Immunol 2007; 37(1) :129-138. (Pubitemid 46128793)
41. Hori S. Rethinking the molecular definition of regulato ry T-cells. Eur J Immunol 2008; 38(4) :928-930.
42. Selvaraj RK, Geiger TL. A kinetic and dynamic analysis of Foxp3 induced in T-cells by TGF-beta. J Immunol 2007: 179(2):1l p following 1390.
43. Marie JC, Letterio JJ, Gavin M, et al. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T-cells.J Exp Med 2005; 201(7) :1061-1067. (Pubitemid 40524674)
44. Li MO, Sanjabi S, FlavellRA. Transforming growth Factor-betacontrols development, homeostasis and tolerance of T-cells by regulatory Tvcell-dependene and -independent mechanisms. Immunity 2006; 25(3) :455-471. (Pubitemid 44354214)
45. Ziegler SF. FOXP3: Not just for regulatory T-cells anymore. Eur J Immunol2007; 37(1) :21-23.
46. Wang R, Wan Q, Kozhaya L, et al. Identification of a regulatory T-cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 2008; 3(7):e2705
47. Samon JB, Champhekar A, Minter LM, et al. Notch l and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T-cells. Blood 2008; 112(5):1813-1821.
48. Burchill MA, YangJ, Vogrenhuber C, et al. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T-cells. J Immunol2007; 178(1):280-290.
49. Mantel PY.Ouaked N, Ruckert B, et al. Molecular mechanisms underlying FOXP3 induction in human T-cells.J 1mmunol 2006; 176(6):3593-3602. (Pubitemid 43364007)
50. Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 2008; 205(3):565-574. (Pubitemid 351439304)
51. Sauer S, Bruno L, Herrweck A, et al. T-cell receptor signaling controls Foxp3 expression via PI3K, Akt and mTOR. Proc Natl Acad Sci USA 2008; 105(22):7797-7802. (Pubitemid 351872718)
52. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectivelyexpands CD4+CD25+FoxP3+ regulatory T-cells. Blood 2005: 105(12):4743-4748.
53. Strauss L, Whiteside TL, Knights A, et al. Selective sur vival of naturally occurring human CD4+CD25+Foxp3+ regulatory T-cells cultured with rapamycin. J Immunol 2007; 178(1):320-329. (Pubitemid 46033615)
54. Yong PL, Russo P, Sullivan KE. Use of sirolimus in IPEX and IPEX-like children. J Clin Irnrnunol 2008: 28(5):581-587.
55. Kim CH. Regulation of FoxP3 regulatory T-cells and Th17 cells by rerinoids. Clin Dev Immunol2008; 2008:416910.
56. Sun CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T- reg cells via retinoic acid. J Exp Med 2007; 204(8) :1775-1785. (Pubitemid 47236316)
57. Gershwin ME, Lentz DR, Beach RS et al. Nutritional factors and autoimmunity. IV. Dietary vitamin A deprivation induces a selective increase in IgM autoant ibodies and hypergammaglobulinemia in New Zealand Black mice. J 1mmunol 1984: 133(1):222-226. (Pubitemid 14077906)
58. Hill lA. Hall lA, Sun CM, et al. Retinoic acid enhances Foxp3 induction indirectly by relievinginhibition from CD4+CD44hi CelIs. Immunity 2008; 29(5) :758-770.
59. Baron U, FloessS. Wieczorek G, et al. DNA demerhylarion in the human FOXP31ocus discriminates regulatory T-cells from activated FOXP3(+) conventional T-cells. Eur 1 Immunol2007; 37(9) :2378-2389. (Pubitemid 47423608)
60. Polan sky lK. Kretschmer K, Freyer L, et al. DNA methylation controls Foxp3 gene expression. Eur 1 Immunol2008; 38(6) :1654-1663.
61. Tone Y, Furuuchi K, Kojima Y, et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008; 9(2):194-202.
62. Takaki H. Ichiyama K, Koga K, et al. STAT6 Inhibits TGF-betal-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. 1 Bioi Chern 2008; 283(22):14955-14962.
63. Lal G. Zhang N. van der Touw Wet al. Epigenetic regulation of Foxp3 expression in regulatory T-cells by DNA methylation. 1 Immunol2009; 182(1):259-273.
64. Curiel TJ, Coukos G. Zou L, et al. Specific recruitment of regulatory T-cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10(9):942-949. (Pubitemid 39273735)
65. Ghiringhelli F, Puig PE. Roux S, et al. Tumor cells convert immature myeloid dendritic cells into 'I'Gl-beta-secrenng cells inducing CD4+CD25+ regulatory T-cell proliferation. 1 Exp Med 2005; 202(7) :919-929. (Pubitemid 41396892)
66. Zhou G. Drake CG. LevitskyHI. Amplification of rumor-specific regulatory T-cellsfolIowingtherapeutic cancer vaccines. Blood 2006; 107(2):628-636. (Pubitemid 43076387)
67. Zhou G. Levitsky HI. Narural regulatory T-celIs and de novo-induced regulatory T-celIs contribute independently to rumor-specific tolerance. 1 Immunol2007; 178(4) :2155-2162 (Pubitemid 46233413)
68. Buil O. Uppaluri R. Hsieh CS, et al. Comparative analysisof regulatory and effector T-cells in progressively growing versus rejecting rumors of similar origins. Cancer Res 2006; 66(14) :7301-7309. (Pubitemid 44197712)
69. Colombo MP, Piconese S. Regulatory-T-celI inhibition versus depletion : The right choice in cancer immunotherapy. Nat Rev Cancer 2007; 7(11):880-887. (Pubitemid 350006256)
70. Liu YC. Wong LY, lang T, et al. Tumor evasion of the immune system by converting CD4+CD25Tvcells int o CD4+CD25+ T-regulatory cells: Role of rumor-derived 'TGf-beca. 1 Immunol 2007 ; 178(5) :2883-2892. (Pubitemid 46333166)
71. Curti A. Pandolfi S. YalzasinaB, et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T-regulatory cells. Blood 2007; 109(7):2871-2877. (Pubitemid 46482083)
72. Fallarino F,Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T-cell receptor zeta-chain and induce a regulatory phenotype in naive 'l-cells Immunol2006; 176(11):6752-6761. (Pubitemid 43787857)
73. Li B. Saouaf SJ, Samanta A, et al. Biochemistry and therapeutic implications ofmechanisms involved in FOXP3 activity in immune suppression. CUrt Opin Immunol2007; 19(5):583-588. (Pubitemid 47487453)
74. Zuo T. Liu R. Zhang H, et al. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.1 Clin Invest 2007; 117(12):3765-3773 (Pubitemid 350224087)
75. Belkaid Y. Piccirillo CA. Mendez S, et al. CD4+CD25+ regulatory T-celIs control Leishmania major persistence and immunity. Nature 2002; 420(6915):502-507. (Pubitemid 35477041)
76. Aseffa A. Gumy A. Launois P, et al. The early IL-4 response to Leishmania major and the resulting Th2 celI maruration steering progressive disease in BALBIc mice are subject to the control of regulatory CD4+CD25+ T-cells. 1 Immunol2002; 169(6):3232-3241. (Pubitemid 35013170)
77. Belkaid Y. Role of Foxp3 -positive regulatory T-cells during infection. Eur 1 Immunol 2008; 38(4) :918-921.
78. Rouse BT, Horohov OW. Immunosuppression in viral infections. Rev Infect Dis 1986; 8(6):850-873.
79. Tortorella D. Gewurz BE, Furman MH, et al. Viral subversion of the immune system.Annu Rev Immunol 2000; 18:861-926. (Pubitemid 30365400)
80. Rouse BT, Deshpande S. Viruses and autoimmuniry: An affair but not a marriage contract. Rev Med Yiro12002; 12(2):107-113. (Pubitemid 34273045)
81. Dittmer U, He H. Messer RJ, et al. Functional impairment of CD8(+) T-cells by regulatory T-cells during persistent retroviral infection Immunity 2004; 20(3) :293-303. (Pubitemid 38388231)
82. SuvasS. Kumaraguru U. Pack CD et at. CD4+CD25+ T-cells regulate virus-specific primary and memory CD8+ T-celI responses. 1 Exp Med 2003; 198(6) :889-901. (Pubitemid 37152926)
83. Iwashiro M. Messer RJ, Peterson KE, et al. Immunosuppression by CD4+ regulatory T-celIs induced by chronic retroviral infection Proc Nad Acad Sci USA 2001; 98(16):9226-9230. (Pubitemid 32743898)
84. Unutmaz D. T-cell signaling mechanisms that regulate HIY-l infection. Immunol Res 2001 ; 23(2-3) :167-177 (Pubitemid 32575358)
85. Grossman Z, Meier-Schellersheirn M. Sousa AE, et al. CD4+ T-cell depletion in HIY infection : Are we closer to understanding the cause? Nat Med 2002; 8(4):319-323. (Pubitemid 34407019)
86. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 1993; 262(5136) :1011-1018. (Pubitemid 24035036)
87. Dunham RM. Cervasi B. BrenchleyJM, et al. CD127 and CD25 expression defines CD4+ Tcell subsers that are differentially depleted during HIV infection.J Immunol 2008; 180(8):5582-5592.
88. Jiang Q,Zhang L. Wang R, et al. FoxP3+CD4+ regulatory T-cells play an important role in acute HIV-l infection in humanized Rag2-/-gammaC-/- mice in vivo. Blood 2008; 112(7):2858-2868.
89. Weiss L. Donkova-Petrini V. Caccavelli L, et al. Human immunodeficiency virus-driven expansion of CD4+CD25+ Regulatory T-cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients Blood 2004; Nov 15;104(10):3249-56 (Pubitemid 39507143)
90. Kintet al. Hennessey M. BellA, et al. CD25(+)CD4(+) regulatory Tvcells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T-cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004; 200(3) :331-343. (Pubitemid 39031252)
91. Aandahl EM, Michaelsson J. Moretto WJ, et al. Human CD4+ CD25+ regulatory T-cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens J Virol 2004; 78(5):2454-2459. (Pubitemid 38228938)
92. Rouse BT, Sarangi PP. Suvas S. Regulatory T-cells in virus infections. Immunol Rev 2006 ; 212:272-286.
93. Holmes D. Knudsen G. Mackey-Cu shman S, et al. FoxP3 enhances HIV-l gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T-cells.J Bioi Chern 2007; 282(22) :15973-15980. (Pubitemid 47100335)
94. Grant C. Oh U. Fugo K, et al. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog 2006; 2(4):e33.
95. Selliah N, Zhang M, White S, et al. FOXP3 inhibits HIV-l infection of CD4 Tvcells via inhibition of LTR transcriptional activity. Virology 2008; 381(2) :161-167.
96. Soiffer R. Immune modulation and chronic grafi-versus-hosr disease. Bone Marrow Transplant 2008; 42(Suppll):S66-S69.
97. Kang SM. Tang Q,BluestoneJA. CD4+CD25+ regulatory T-cells in transplantation : Progress. challenges and prospects. AmJ Transplant 2007; 7(6):1457-1463. (Pubitemid 46776267)
98. Vandenbark AA. Offner H. Critical evaluation of regulatory T-cells in autoimmunit y: Are the most potent regularory specificities being ignored ? Immunology 2008; 125(1):1-13.
99. Olivares-VillagomezD, Wang Y. Lafaillen. Regulatory CD4(+) T-cells expressing endogenous T-cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneou s autoimmune encephalomyelitis.J Exp Med 1998; 188(10):1883-1894. (Pubitemid 28536776)
100. Iwase K. Shimada A, Kawai T, et al. FOXP3/Scurfin gene polymorphism is associated with adult onset type 1 diabetes in Japanese. especially in women and slowly progressive-type patients. Autoimmunity 2008:1.
101. KivlingA, Nilsson L. Falth-MagnussonK, et al. Diverse foxp3 expression in children with type 1 diabetes and celiac disease. Ann NY Acad Sci 2008: 1150:273-277.
102. Pop SM. Wong CPo Culton DA, et al. Single cell analysis shows decreasing FoxP3 and TGFbetal coexpressing CD4+CD25+ regulato ry T-cells during autoimmune diabetes. J Exp Med 2005 : 201(8) :1333-1346. (Pubitemid 40629075)
103. Schneider A. Rieck M, Sanda S, et al. The effector Tvcells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T-cells.J Immunol 2008: 181(10):7350-7355.
104. Waid DM. Vaitaitis GM, Pennock ND, et al. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T-cells promotes diabetes J Leukoc Bioi 2008: 84(2) :431-439.
105. Feuerer M, Jiang W; Holler PD, et al. Enhanced thymic selection of FoxP3+ regulatory 'Tcells in the NOD mouse model of autoimmune diabetes. Proc Natl Acad Sci USA 2007; 104(46):18181-18186. (Pubitemid 350210841)
106. Mellanby RJ. Thomas D, PhillipsJM, et al. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T-cells. Immunology 2007; 121(1):15-28. (Pubitemid 46537670)
107. Jaeckel E. Mpofu N. SaalNet al. Role of regulatory T-cells for the treatment of type I diabetes mellitus. Horm Metab Res 2008; 40(2) :126-136. (Pubitemid 351363424)